Orphan Drug Designation Archives - Page 2 of 2 - Express Pharma

USFDA approves Inmazeb from Regeneron Pharma to treat Ebola

TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome

Trodelvy from Immunomedics gets US FDA orphan drug designation for glioblastoma

US FDA grants orphan drug designation to oNKord from Glycostem for multiple myeloma

USFDA approves Nucala to treat hypereosinophilic syndrome

US FDA grants Lupin’s Mexiletine Orphan Drug Designation

SPARC gets orphan drug designation for Phenobarbital from US FDA

Glenmark receives Orphan Drug Designation for GBR 1342

Stempeutics receives ODD in the European Union for Stempeucel